Topline results from metastatic breast cancer phase 3 trial
Updated prostate cancer results show anti-tumour activity
Gesynta Pharma continues endometriosis work
First-in-human circular RNA therapy for radiation-induced xerostomia
IASO acquires cell therapy company MediSix
Jazz Pharmaceuticals to acquire Actio Biosciences and expand rare epilepsy portfolio
Tagomics introduces cfDNA-based blood test for multi-organ drug safety monitoring
Base to Base biotech podcast 71: The IgA/CD89 axis
Activating human killer T-cells against cancer
Spinal Muscular Atrophy Awareness Month begins with spotlight on care gaps
University of Aberdeen-led team to trial new drug for heavy menstrual bleeding
Bristol Myers Squibb announces $2.3bn campus in Texas